Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bendik Lund

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2019
Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized StudyBirgitte Klug Albertsen, Kathrine Grell, Jonas Abrahamsson, et al.
Frontiers in Neurology|January 22, 2024
Intelligence and executive function are associated with age at insult, time post-insult, and disability following chronic pediatric acquired brain injuryAnne Elisabeth Brandt, Torstein B Rø, Torun G Finnanger, et al.
Cancer Chemotherapy and Pharmacology|October 17, 2018
Methotrexate polyglutamate levels and co-distributions in childhood acute lymphoblastic leukemia maintenance therapyJacob Nersting, Stine Nygaard Nielsen, Kathrine Grell, et al.
Trials|February 8, 2017
The WE-Study: does botulinum toxin A make walking easier in children with cerebral palsy?: Study protocol for a randomized controlled trialSiri Merete Brændvik, Karin Roeleveld, Guro Lillemoen Andersen, et al.
European Journal of Haematology|October 7, 2017
Individualized 6-mercaptopurine increments in consolidation treatment of childhood acute lymphoblastic leukemia: A NOPHO randomized controlled trialMorten Tulstrup, Thomas L Frandsen, Jonas Abrahamsson, et al.
The Lancet. Oncology|March 5, 2017
DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trialStine Nygaard Nielsen, Kathrine Grell, Jacob Nersting, et al.
Scandinavian Journal of Infectious Diseases|October 6, 2007
Febrile neutropenia in children with cancer: a retrospective Norwegian multicentre study of clinical and microbiological outcomeNiklas Stabell, Ellen Nordal, Einar Stensvold, et al.
Cancer Reports (Hoboken, N.J.)|September 20, 2021
The Norwegian childhood cancer biobankJohanne U Hermansen, Dorota M Wojcik, Nina Robinson, et al.
European Journal of Haematology|September 10, 2020
Impact of body mass index on relapse in children with acute lymphoblastic leukemia treated according to Nordic treatment protocolsChristina Egnell, Susanna Ranta, Joanna Banerjee, et al.
Pediatric Hematology and Oncology|November 18, 2020
<i>TPMT</i> polymorphisms and minimal residual disease after 6-mercaptopurine post-remission consolidation therapy of childhood acute lymphoblastic leukaemiaKarin Dreisig, Emilie Damgaard Brünner, Hanne V Marquart, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2019
Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized StudyBirgitte Klug Albertsen, Kathrine Grell, Jonas Abrahamsson, et al.
Frontiers in Neurology|January 22, 2024
Intelligence and executive function are associated with age at insult, time post-insult, and disability following chronic pediatric acquired brain injuryAnne Elisabeth Brandt, Torstein B Rø, Torun G Finnanger, et al.
Cancer Chemotherapy and Pharmacology|October 17, 2018
Methotrexate polyglutamate levels and co-distributions in childhood acute lymphoblastic leukemia maintenance therapyJacob Nersting, Stine Nygaard Nielsen, Kathrine Grell, et al.
Trials|February 8, 2017
The WE-Study: does botulinum toxin A make walking easier in children with cerebral palsy?: Study protocol for a randomized controlled trialSiri Merete Brændvik, Karin Roeleveld, Guro Lillemoen Andersen, et al.
European Journal of Haematology|October 7, 2017
Individualized 6-mercaptopurine increments in consolidation treatment of childhood acute lymphoblastic leukemia: A NOPHO randomized controlled trialMorten Tulstrup, Thomas L Frandsen, Jonas Abrahamsson, et al.
The Lancet. Oncology|March 5, 2017
DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trialStine Nygaard Nielsen, Kathrine Grell, Jacob Nersting, et al.
Scandinavian Journal of Infectious Diseases|October 6, 2007
Febrile neutropenia in children with cancer: a retrospective Norwegian multicentre study of clinical and microbiological outcomeNiklas Stabell, Ellen Nordal, Einar Stensvold, et al.
Cancer Reports (Hoboken, N.J.)|September 20, 2021
The Norwegian childhood cancer biobankJohanne U Hermansen, Dorota M Wojcik, Nina Robinson, et al.
European Journal of Haematology|September 10, 2020
Impact of body mass index on relapse in children with acute lymphoblastic leukemia treated according to Nordic treatment protocolsChristina Egnell, Susanna Ranta, Joanna Banerjee, et al.
Pediatric Hematology and Oncology|November 18, 2020
<i>TPMT</i> polymorphisms and minimal residual disease after 6-mercaptopurine post-remission consolidation therapy of childhood acute lymphoblastic leukaemiaKarin Dreisig, Emilie Damgaard Brünner, Hanne V Marquart, et al.
Pageof 4